127 related articles for article (PubMed ID: 17323884)
1. [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
Soetekouw PM; Gijtenbeek JM; van der Maazen RW; Kappelle AC; van Herpen CM
Ned Tijdschr Geneeskd; 2007 Jan; 151(4):253-7. PubMed ID: 17323884
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
3. Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide.
Jalali R; Singh P; Menon H; Gujral S
J Neurooncol; 2007 Oct; 85(1):105-7. PubMed ID: 17505778
[TBL] [Abstract][Full Text] [Related]
4. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
Chamberlain MC; Tsao-Wei DD
Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
[TBL] [Abstract][Full Text] [Related]
5. Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.
Singhal N; Selva-Nayagam S; Brown MP
J Neurooncol; 2007 Nov; 85(2):229-30. PubMed ID: 17530175
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide-associated organizing pneumonitis.
Maldonado F; Limper AH; Lim KG; Aubrey MC
Mayo Clin Proc; 2007 Jun; 82(6):771-3. PubMed ID: 17550757
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
Chou KN; Lin YC; Liu MY; Chang PY
J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
9. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
Tan CW; See SJ; Tham CK; Ang AL
Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
[No Abstract] [Full Text] [Related]
10. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
Nagasawa DT; Chow F; Yew A; Kim W; Cremer N; Yang I
Neurosurg Clin N Am; 2012 Apr; 23(2):307-22, ix. PubMed ID: 22440874
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.
Chinot OL; Barrie M; Frauger E; Dufour H; Figarella-Branger D; Palmari J; Braguer D; Hoang-Xuan K; Moktari K; Peragut JC; Martin PM; Grisoli F
Cancer; 2004 May; 100(10):2208-14. PubMed ID: 15139066
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
13. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
Villano JL; Collins CA; Manasanch EE; Ramaprasad C; van Besien K
Lancet Oncol; 2006 May; 7(5):436-8. PubMed ID: 16648049
[No Abstract] [Full Text] [Related]
14. A rare case of aplastic anemia caused by temozolomide.
George BJ; Eichinger JB; Richard TJ
South Med J; 2009 Sep; 102(9):974-6. PubMed ID: 19668033
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide (Temodar).
Wesolowski JR; Rajdev P; Mukherji SK
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
[TBL] [Abstract][Full Text] [Related]
16. The safety of temozolomide in the treatment of malignancies.
Trinh VA; Patel SP; Hwu WJ
Expert Opin Drug Saf; 2009 Jul; 8(4):493-9. PubMed ID: 19435405
[TBL] [Abstract][Full Text] [Related]
17. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
Meije Y; Lizasoain M; García-Reyne A; Martínez P; Rodríguez V; López-Medrano F; Juan RS; Lalueza A; Aguado JM
Clin Infect Dis; 2010 Jun; 50(12):e73-6. PubMed ID: 20455691
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphoma in a patient on treatment with temozolomide.
Otty Z; Sabesan S
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e53-4. PubMed ID: 22897453
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution.
Teixeira MM; Garcia I; Portela I; Cernuda M; Oliveira C; Albano J; Lima L
Int J Clin Pharmacol Res; 2002; 22(1):19-22. PubMed ID: 12395915
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of temozolomide in patients with myelodysplastic syndrome.
Seiter K; Liu D; Siddiqui AD; Lerner R; Nelson J; Ahmed T
Leuk Lymphoma; 2004 Jun; 45(6):1209-14. PubMed ID: 15360003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
